Karyopharm Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.90

+0.05 (+0.57%)

As of May 16, 2:12 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 2 15%

Sell 0 0%

Price Target

Analyst Price Target +452.1% upside

Low Target $31.72

Average Target $49.14

High Target $61.64

Current Price $8.90

Current
$8.90

Target
$49.14

$31.72 $49.14 avg $61.64

Scenario Analysis

Bear Case

$31.72

256.4%

Low target

Base Case

$49.14

+452.1%

Avg target

Bull Case

$61.64

+592.6%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$10.99

-19.0% from high

52-Week Low

$3.65

+143.8% from low

Target vs 52W High

$49.14

+347.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%